her1
her1 is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at her1.
her1 is a company.
Key people at her1.
her1 is a Berlin-based direct-to-consumer wellness company founded in 2017 that develops natural, plant-based ingestible products to support women's health by targeting gut health, microbiome balance, and related issues like skin, hormones, mood, sleep, and holistic wellbeing.[1][2][3] Its flagship product, Inner Beauty—a "pink drink" with over 25 billion active microorganisms per serving—launched in 2019, followed by Gut One, a probiotic and B-vitamin supplement for gut-brain axis support, both available via subscription.[1][2][3] her1 serves women across Europe, solving taboos around digestive and female-specific health through science-backed, EU organic-certified (DE-ÖKO-070), gluten- and sugar-free blends from locally sourced whole foods, with strong growth including 815% YoY in the year prior to 2021 and 55% quarterly increases, backed by €9M total funding including a €5.5M Series A in 2021 led by Five Seasons Ventures.[1][2][3][4]
The company employs a 35-person team focused on product innovation, European expansion (starting from German-speaking markets), and multilingual accessibility, aiming to become the leading digital health impact brand for female wellbeing across life stages like pregnancy and menopause.[1][2][4]
her1 was founded in 2017 by serial FoodTech entrepreneur Chanyu Xu, who drew from her expertise to address gut health as the foundation of overall wellbeing, encapsulated in her mantra: "you are what you eat and everything starts from within."[1][2] After over a year of research and development, the company launched its debut product, Inner Beauty, in 2019, marking early traction in German-speaking countries with natural probiotics and prebiotics.[1][3]
Pivotal moments include rapid scaling—achieving over 54k loyal recurring customers, 25k+ Instagram followers, and double-digit month-over-month growth by 2021—culminating in the €5.5M Series A round in June/July 2021, led by Five Seasons Ventures with participation from Rheingau Founders and IBB Ventures, bringing total funding to €9M.[1][2][3][4] This funding fueled team expansion in finance, marketing, and product roles, plus new launches like Gut One.[1][2]
her1 rides the exploding gut health and women's wellness trends, tapping into rising microbiome awareness amid a $300B global supplements market and $60B probiotics segment, where 62% of people face yearly digestive issues often shrouded in taboo.[4] Timing aligns with post-2020 health consciousness surges, European DTC e-commerce growth, and demand for "inside-out" beauty/health solutions over topical fixes, amplified by research linking gut to mental, immune, and skin health.[2][3][4]
Market forces like sustainable, organic consumer preferences and life-stage personalization (e.g., pregnancy vitamins, menopause support) favor her1's Europe-focused expansion from a Berlin base.[1][4] It influences the ecosystem by pioneering female-led FoodTech in ingestibles, inspiring "for women, by women" brands, and validating DTC models in wellness tech with data-driven scaling.[4]
her1 is poised to dominate European women's gut-centric wellness with its science pipeline, subscription retention, and funding momentum, potentially launching products for hormone, sleep, and mood needs while scaling multilingual DTC.[1][2][4] Trends like AI-personalized nutrition, deeper microbiome science, and sustainability mandates will shape its path, possibly fueling Series B for UK/France penetration or US entry amid $60B+ probiotics growth.[4]
As a 2017-founded trailblazer with 815% early surges, her1 exemplifies how gut health innovation unlocks female wellbeing at scale—watch for it to redefine DTC ingestibles across life stages.[2][4]
Key people at her1.
